Amit Singh Selected Research

Contrast Media

1/2016	Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.
8/2015	EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amit Singh Research Topics

Disease

37	Neoplasms (Cancer) 05/2024 - 10/2010
26	Infections 08/2024 - 08/2009
26	Tuberculosis (Tuberculoses) 03/2024 - 05/2005
13	COVID-19 01/2024 - 11/2020
8	Inflammation (Inflammations) 03/2024 - 01/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 10/2014
6	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 01/2013
6	Hypertension (High Blood Pressure) 10/2022 - 10/2018
6	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 10/2012
5	Lung Neoplasms (Lung Cancer) 12/2021 - 12/2013
4	Carcinogenesis 04/2023 - 05/2013
4	Bacterial Infections (Bacterial Infection) 01/2023 - 11/2018
3	Body Weight (Weight, Body) 01/2023 - 01/2014
3	Fibrosis (Cirrhosis) 01/2023 - 04/2019
3	Neoplasm Metastasis (Metastasis) 11/2019 - 05/2013
3	Adenocarcinoma 01/2017 - 01/2015
2	Periprosthetic Fractures 03/2024 - 01/2014
2	Hypoxia (Hypoxemia) 12/2023 - 01/2023
2	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2021
2	Ankylosing Spondylitis 02/2023 - 03/2022
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023 - 01/2022
2	Necrosis 01/2023 - 01/2021
2	Coinfection 01/2022 - 11/2019
2	Starvation 01/2022 - 07/2007
2	Wounds and Injuries (Trauma) 09/2021 - 08/2021
2	Hypersensitivity (Allergy) 08/2021 - 11/2018
2	Treatment-Resistant Depressive Disorder 04/2021 - 05/2017
2	Pain (Aches) 03/2021 - 04/2018
2	Disease Progression 11/2020 - 08/2015
2	Type 2 Diabetes Mellitus (MODY) 07/2020 - 10/2019
2	Amyloid Plaque 01/2020 - 01/2015
2	Edema (Dropsy) 04/2019 - 10/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2016 - 02/2014
2	Craniosynostoses (Craniosynostosis) 04/2014 - 10/2013

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2012
9	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2014
7	VaccinesIBA 04/2023 - 07/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 12/2013
6	Amyloid beta-PeptidesIBA 04/2023 - 01/2015
6	LipidsIBA 07/2020 - 08/2009
6	Peptides (Polypeptides)IBA 01/2020 - 01/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2014
5	ChitosanIBA 01/2021 - 10/2014
5	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 09/2014
4	JNK Mitogen-Activated Protein KinasesIBA 05/2024 - 01/2021
4	Transcription Factors (Transcription Factor)IBA 05/2024 - 02/2014
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 11/2018
4	AntigensIBA 01/2022 - 01/2014
4	PlatinumIBA 01/2017 - 09/2014
4	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2015
4	Hyaluronic Acid (Hyaluronan)IBA 01/2017 - 01/2015
4	ErbB Receptors (EGF Receptor)IBA 04/2016 - 10/2014
3	Isoniazid (Ftivazide)FDA LinkGeneric 04/2022 - 01/2018
3	SolutionsIBA 03/2022 - 10/2013
3	Glutathione (Reduced Glutathione)IBA 01/2017 - 01/2014
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 03/2024 - 12/2023
2	RNA (Ribonucleic Acid)IBA 01/2024 - 02/2022
2	Protein Kinase InhibitorsIBA 12/2023 - 04/2023
2	Nucleic AcidsIBA 10/2023 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 07/2023 - 12/2021
2	CytokinesIBA 07/2023 - 11/2013
2	CreatinineIBA 01/2023 - 10/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 11/2013
2	Antiviral Agents (Antivirals)IBA 01/2023 - 11/2020
2	CholesterolIBA 10/2022 - 07/2020
2	Histones (Histone)IBA 06/2022 - 01/2020
2	GoldIBA 03/2022 - 01/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 03/2022 - 01/2021
2	NAD (NADH)IBA 01/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 08/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 08/2021 - 02/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 07/2017
2	Blood Glucose (Blood Sugar)IBA 07/2020 - 11/2013
2	Olanzapine (Zyprexa)FDA Link 03/2017 - 02/2017
2	Gemcitabine FDA Link 04/2016 - 02/2014
2	GelatinIBA 04/2016 - 02/2014
2	Melanocyte-Stimulating Hormones (MSH)IBA 02/2016 - 01/2014
2	mycothiolIBA 02/2016 - 01/2014
2	Contrast MediaIBA 01/2016 - 08/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2015 - 02/2015
2	Superoxide DismutaseIBA 04/2015 - 01/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 07/2007
2	Phosphotransferases (Kinase)IBA 05/2013 - 05/2005
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2009 - 06/2005
1	BuffersIBA 08/2024
1	Acetates (Acetic Acid Esters)FDA Link 04/2024
1	thionineIBA 04/2024

Therapy/Procedure

45	Therapeutics 03/2024 - 10/2010
7	Drug Therapy (Chemotherapy) 07/2023 - 09/2014
3	Lasers (Laser) 04/2024 - 12/2016
3	Transcranial Direct Current Stimulation 11/2023 - 11/2022
3	Precision Medicine 01/2016 - 09/2014
2	Phototherapy (Light Therapy) 04/2024 - 12/2022
2	Duration of Therapy 03/2024 - 01/2020
2	Transcranial Magnetic Stimulation 10/2022 - 05/2017
2	Conservative Treatment 05/2021 - 01/2021
2	Operative Surgical Procedures 07/2018 - 04/2014
2	Stents 01/2015 - 01/2014
1	Intranasal Administration 08/2024